Furthermore, we presented the distribution of BC subtypes (HER2−/HR+, HER2+/HR+, HER2+/HR−, HER2-low/HR+, HER2-low/HR−, HER2−/HR−) according to PAM50 intrinsic subtypes. Here, ERBB2 is linked to breast cancer.